View Author
irinotecan patient cancer study pharmacokinetic treatment level effect sn -38 -38 diarrhea follicle cannabi allele group activin cyp 3a polymorphism grade value variant women ugt 1a genotype cycle sn -38g analysis result number table clearance neomycin oncol parameter cancer patients toxicity inhibin phase irinotecan pharmacokinetics hormone chapter metabolite difference expression frequency metabolism verweij j osteoblast protein midazolam plasma irinotecan-induced activity pharmacogenetic ratio population mineralization therapy dosing mathijssen verweij infusion inhibin b weight variability culture irinotecan-induced diarrhea blood trial e 2 levels function colorectal delayed-type jong fa erythromycin breath test transporter fracture sample netherland serum
10 Most Recent Publications
|
Letter
(Article)
Jong, F.A. de Verweij, J. Sparreboom, A. |
2008-09-01
|
|
Estradiol improves cerebellar memory formation by activating estrogen receptor β
(Article)
Andreescu, C.E. Milojkovic, B.A. Haasdijk, E.D. Kramer, P. Jong, F.A. de Krust, A. Zeeuw, C.I. de Jeu, M.T.G. de |
2007-10-03
|
|
Anti-Müllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood
(Article)
Beek, R.D. van Heuvel-Eibrink, M.M. van den Laven, J.S.E. Jong, F.A. de Themmen, A.P.N. Hakvoort-Cammel, F.G.A.J. Bos, C. van den Berg, H. van den Pieters, R. Muinck Keizer-Schrama, S.M.P.F. de |
2007-10-01
|
|
The activin A-follistatin system: Potent regulator of human extracellular matrix mineralization
(Article)
Eijken, H.J.M. Swagemakers, S.M.A. Leeuwen, J.P.T.M. van Koedam, M. Steenbergen, C. Derkx, P. Uitterlinden, A.G. Spek, P.J. van der Visser, J.A. Jong, F.A. de Pols, H.A.P. |
2007-09-01
|
|
The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men
(Article)
Stolk, L. Meurs, J.B.J. van Jhamai, M. Arp, P.P. Leeuwen, J.P.T.M. van Hofman, A. Jong, F.A. de Pols, H.A.P. Uitterlinden, A.G. |
2007-08-01
|
|
Loss of ovarian reserve after uterine artery embolization: A randomized comparison with hysterectomy
(Article)
Hehenkamp, W.J.K. Volkers, N.A. Broekmans, F.J.M. Jong, F.A. de Themmen, A.P.N. Birnie, E. Reekers, J.A. Ankum, W.M. |
2007-07-01
|
|
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women
(Article)
Kevenaar, M.E. Themmen, A.P.N. Laven, J.S.E. Sonntag, B. Lie Fong, S. Uitterlinden, A.G. Jong, F.A. de Pols, H.A.P. Simoni, M. Visser, J.A. |
2007-06-01
|
|
Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice
(Article)
Visser, J.A. Durlinger, A.L.L. Peters, I.J.J. Heuvel, E.R. van den Rose, U.M. Kramer, P. Jong, F.A. de Themmen, A.P.N. |
2007-05-01
|
|
Predictors of recovery of ovarian function during weight gain in anorexia nervosa
(Article)
Elburg, A.A. van Eijkemans, M.J.C. Kas, M.J.H. Themmen, A.P.N. Jong, F.A. de Engeland, H. van Fauser, B.C.J.M. |
2007-04-01
|
|
A Roadmap to Individualized Irinotecan Dosing
(Doctoral Thesis)
Jong, F.A. de |
2006-10-11
|
